Calpain proteolysis of insulin-like growth factor binding protein (IGFBP) -2 and -3, but not of IGFBP-1

Biological Chemistry

Volumn 388, Issue 8, 2007, Pages 859-863

  Berg, Ulrika ^a,b   Bang, Peter ^a   Carlsson Skwirut, Christine ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biosensor analysis; Ca2+ activation; Cleavage site; Fragmentation; Kinetics; Protease

Indexed keywords

CALCIUM; CALPAIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOLYSIS; BIOSENSOR; CALCIUM METABOLISM; CONCENTRATION (PARAMETERS); DOSE RESPONSE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN LOCALIZATION;

BIOSENSING TECHNIQUES; CALCIUM; CALPAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TIME FACTORS;

EID: 34547554097     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.098     Document Type: Article

References (37)

1. Bach, L.A., Headey, S.J., and Norton, R.S. (2005). IGF-binding proteins - the pieces are falling into place. Trends Endocrinol. Metab. 16, 228-234.
2. Bang, P., Brismar, K., and Rosenfeld, R.G. (1994). Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J. Clin. Endocrinol. Metab. 78, 1119-1127.
3. Bayol, S., Loughna, P.T., and Brownson, C. (2000). Phenotypic expression of IGF binding protein transcripts in muscle, in vitro and in vivo. Biochem. Biophys. Res. Commun. 273, 282-286.
4. Bereket, A., Lang, C.H., Blethen, S.L., Gelato, M.C., Fan, J., Frost, R.A., and Wilson, T.A. (1995). Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 80, 1312-1317.
5. Campbell, P.G., Novak, J.F., Wines, K., and Walton, P.E. (1993). Localization of plasmin activity on osteosarcoma cells: cell surface proteolysis of insulin-like growth factor binding proteins. Growth Regul. 3, 95-98.
6. Chan, S.S., Twigg, S.M., Firth, S.M., and Baxter, R.C. (2005). Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J. Clin. Endocrinol. Metab. 90, 6588-6595.
7. Chen, X. and Ferry, R.J. Jr. (2006). Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells. Growth Horm. IGF Res. 16, 41-48.
8. Claussen, M., Kubler, B., Wendland, M., Neifer, K., Schmidt, B., Zapf, J., and Braulke, T. (1997). Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 138, 3797-3803.
9. Cohen, P., Graves, H.C., Peehl, D.M., Kamarei, M., Giudice, L.C., and Rosenfeld, R.G. (1992). Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 75, 1046-1053.
10. Cwyfan Hughes, S.C., Cotterill, A.M., Molloy, A.R., Cassell, T.B., Braude, N., Hinds, C.J., Wass, J.A., and Holly, J.M. (1992). The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. J. Endocrinol. 135, 135-145.
11. 2+ requirement, and heterodimer stability in m-calpain. J. Biol. Chem. 272, 11268-11275.
12. Fielder, P.J., Rosenfeld, R.G., Graves, H.C., Grandbois, K., Maack, C.A., Sawamura, S., Ogawa, Y., Sommer, A., and Cohen, P. (1994). Biochemical analysis of prostate specific antigen-proteolyzed insulin-like growth factor binding protein-3. Growth Regul. 4, 164-172.
13. Firth, S.M. and Baxter, R.C. (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854.
14. Friedrich, P. and Bozoky, Z. (2005). Digestive versus regulatory proteases: on calpain action in vivo. Biol. Chem. 386, 609-612.
15. Ghosh, M., Shanker, S., Siwanowicz, I., Mann, K., Machleidt, W., and Holak, T.A. (2005). Proteolysis of insulin-like growth factor binding proteins (IGFBPs) by calpain. Biol. Chem. 386, 85-93.
16. Gibson, J.M., Aplin, J.D., White, A., and Westwood, M. (2001). Regulation of IGF bioavailability in pregnancy. Mol. Hum. Reprod. 7, 79-87.
17. Giudice, L.C. (2001). Insulin-like growth factor family in Graafian follicle development and function. J. Soc. Gynecol. Invest. 8, S26-29.
18. Giudice, L.C., Farrell, E.M., Pham, H., Lamson, G., and Rosenfeld, R.G. (1990). Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J. Clin. Endocrinol. Metab. 71, 806-816.
19. Goll, D.E., Thompson, V.F., Li, H., Wei, W., and Cong, J. (2003). The calpain system. Physiol. Rev. 83, 731-801.
20. Hoeflich, A., Reisinger, R., Lahm, H., Kiess, W., Blum, W.F., Kolb, H.J., Weber, M.M., and Wolf, E. (2001). Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res. 61, 8601-8610.
21. Hoeflich, A., Reisinger, R., Schuett, B.S., Elmlinger, M.W., Russo, V.C., Vargas, G.A., Jehle, P.M., Lahm, H., Renner-Muller, I., and Wolf, E. (2004). Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-terminal IGFBP-2 fragment in vivo. Biochem. Biophys. Res. Commun. 324, 705-710.
22. Hossenlopp, P., Segovia, B., Lassarre, C., Roghani, M., Bredon, M., and Binoux, M. (1990). Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J. Clin. Endocrinol. Metab. 71, 797-805.
23. Irwin, J.C., Suen, L.F., Martina, N.A., Mark, S.P., and Giudice, L.C. (1999). Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum. Reprod. 14 (Suppl. 2), 90-96.
24. Lee, K.W., Liu, B., Ma, L., Li, H., Bang, P., Koeffler, H.P., and Cohen, P. (2004). Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J. Biol. Chem. 279, 469-476.
25. Longobardi, L., Torello, M., Buckway, C., O'Rear, L., Horton, W.A., Hwa, V., Roberts, C.T. Jr., Chiarelli, F., Rosenfeld, R.G., and Spagnoli, A. (2003). A novel insulin-like growth factor (IGF)-independent role for IGF binding protein-3 in mesenchymal chondroprogenitor cell apoptosis. Endocrinology 144, 1695-1702.
26. Maile, L.A. and Holly, J.M. (1999). Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm. IGF Res. 9, 85-95.
27. Mark, S., Kubler, B., Honing, S., Oesterreicher, S., John, H., Braulke, T., Forssmann, W.G., and Standker, L. (2005). Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern. Biochemistry 44, 3644-3652.
28. Nemet, D., Oh, Y., Kim, H.S., Hill, M., and Cooper, D.M. (2002). Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 110, 681-689.
29. Paul, D.S., Harmon, A.W., Winston, C.P., and Patel, Y.M. (2003). Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J. 376, 625-632.
30. Radulescu, R.T. (1994). Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem. Sci. 19, 278.
31. Ricort, J.M. (2004). Insulin-like growth factor binding protein (IGFBP) signalling. Growth Horm. IGF Res. 14, 277-286.
32. Schwarz, A.J., Brasel, J.A., Hintz, R.L., Mohan, S., and Cooper, D.M. (1996). Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J. Clin. Endocrinol. Metab. 81, 3492-3497.
33. Sreenan, S.K., Zhou, Y.P., Otani, K., Hansen, P.A., Currie, K.P., Pan, C.Y., Lee, J.P., Ostrega, D.M., Pugh, W., Horikawa, Y., et al. (2001). Calpains play a role in insulin secretion and action. Diabetes 50, 2013-2020.
34. Tompa, P., Buzder-Lantos, P., Tantos, A., Farkas, A., Szilagyi, A., Banoczi, Z., Hudecz, F., and Friedrich, P. (2004). On the sequential determinants of calpain cleavage. J. Biol. Chem. 279, 20775-20785.
35. Turner, M.D., Cassell, P.G., and Hitman, G.A. (2005). Calpain-10: from genome search to function. Diabetes Metab. Res. Rev. 21, 505-514.
36. Wendt, A., Thompson, V.F., and Goll, D.E. (2004). Interaction of calpastatin with calpain: a review. Biol. Chem. 385, 465-472.
37. Zhou, Y.P., Sreenan, S., Pan, C.Y., Currie, K.P., Bindokas, V.P., Horikawa, Y., Lee, J.P., Ostrega, D., Ahmed, N., Baldwin, A.C., et al. (2003). A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52, 528-534.